• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device has supplements. The device description may have changed. Be sure to look at the supplements to get an up-to-date view of this device.
Classification Namekit, dna detection, human papillomavirus
Generic Namekit, dna detection, human papillomavirus
250 campus drive
marlborough, MA 01750
PMA NumberP080014
Date Received04/28/2008
Decision Date03/12/2009
Product Code
MAQ[ Registered Establishments with MAQ ]
Docket Number 09M-0299
Notice Date 06/30/2009
Advisory Committee Microbiology
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the cervista hpv hr and genfind dna extraction kit. Cervista hpv hr indications for use: the cervista hpv hr test is an in vitro diagnostic test for the qualitative detection of dnafrom 14 high-risk- human papillomavirus (hpv) types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58,59, 66, and 68) in cervical specimens. The cervista hpv hr test cannot determine thespecific hpv type present. The cervista hpv hr test uses the invader chemistry, a signal amplification method fordetection of specific nucleic acid sequences. This method uses two types of isothermal reactions:a primary reaction that occurs on the targeted dna sequence and a secondary reaction that produces a fluorescent signal. The cervista hpv hr test is indicated:1) to screen patients with atypical squamous cells of undetermined significance (ascus)cervical cytology results to determine the need for referral to colposcopy. 2) in women 30 years and older the cervista hpv hr test can be used with cervicalcytology to adjunctively screen to assess the presence or absence of high-risk hpvtypes. This information, together with the physician's assessment of cytology history,other risk factors, and professional guidelines, may be used to guide patientmanagement. Cervical specimens that may be tested with the cervista hpv hr test include the followingpreservation system collection media and collection devices:¿ thinprep pap test preservcyt solution¿ broom-type device (e. G. Rovers cervex brush, wallach papette), or endocervicalbrush/spatula. Genfind dna extraction kit indication for use:the genfind dna extraction kit is intended for use in the extraction of dna fromcervical specimens collected in thinprep pap test preservcyt solution for testingby the cervista hpv hr and cervista hpv 16/18 tests.
Approval Order Approval Order
Summary Summary of Safety and Effectiveness
Labeling Labeling
Post-Approval StudyShow Report Schedule and Study Progress
Supplements: S001 S002 S003 S004 S005 S006 S007 S008 S009 
S010 S011 S012 S013 S014 S015 S016 S017 S018 
S019 S020